Literature DB >> 16477036

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

Cecile Martinat1, Jean-Jacques Bacci, Thomas Leete, Jongpil Kim, William B Vanti, Amy H Newman, Joo H Cha, Ulrik Gether, Honggang Wang, Asa Abeliovich.   

Abstract

Midbrain dopamine (DA) neurons play a central role in the regulation of voluntary movement, and their degeneration is associated with Parkinson's disease. Cell replacement therapies, and in particular embryonic stem (ES) cell-derived DA neurons, offer a potential therapeutic venue for Parkinson's disease. We sought to identify genes that can potentiate maturation of ES cell cultures to the midbrain DA neuron phenotype. A number of transcription factors have been implicated in the development of midbrain DA neurons by expression analyses and loss-of-function knockout mouse studies, including Nurr1, Pitx3, Lmx1b, Engrailed-1, and Engrailed-2. However, none of these factors appear sufficient alone to induce the mature midbrain DA neuron phenotype in ES cell cultures in vitro, suggesting a more complex regulatory network. Here we show that Nurr1 and Pitx3 cooperatively promote terminal maturation to the midbrain DA neuron phenotype in murine and human ES cell cultures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477036      PMCID: PMC1413837          DOI: 10.1073/pnas.0511153103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.

Authors:  J Wagner; P Akerud; D S Castro; P C Holm; J M Canals; E Y Snyder; T Perlmann; E Arenas
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

2.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

3.  Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

Authors:  H Kawasaki; K Mizuseki; S Nishikawa; S Kaneko; Y Kuwana; S Nakanishi; S I Nishikawa; Y Sasai
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

4.  Coordinate roles for LIM homeobox genes in directing the dorsoventral trajectory of motor axons in the vertebrate limb.

Authors:  A Kania; R L Johnson; T M Jessell
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

5.  Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.

Authors:  P Sacchetti; T R Mitchell; J G Granneman; M J Bannon
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

6.  Fate of midbrain dopaminergic neurons controlled by the engrailed genes.

Authors:  H H Simon; H Saueressig; W Wurst; M D Goulding; D D O'Leary
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

7.  A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b.

Authors:  M P Smidt; C H Asbreuk; J J Cox; H Chen; R L Johnson; J P Burbach
Journal:  Nat Neurosci       Date:  2000-04       Impact factor: 24.884

8.  Hyperactivity and impaired response habituation in hyperdopaminergic mice.

Authors:  X Zhuang; R S Oosting; S R Jones; R R Gainetdinov; G W Miller; M G Caron; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

9.  Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain.

Authors:  K Sakurada; M Ohshima-Sakurada; T D Palmer; F H Gage
Journal:  Development       Date:  1999-09       Impact factor: 6.868

10.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.

Authors:  S Srinivas; T Watanabe; C S Lin; C M William; Y Tanabe; T M Jessell; F Costantini
Journal:  BMC Dev Biol       Date:  2001-03-27       Impact factor: 1.978

View more
  72 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  Modulation of dopaminergic neuronal differentiation from sympathoadrenal progenitors.

Authors:  Vladimir Vukicevic; Maria F Rubin de Celis; Gabriela Diaz-Valencia; Stefan R Bornstein; Monika Ehrhart-Bornstein
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

Review 3.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

Review 4.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

Review 5.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 6.  Stem cell transplantation: a promising therapy for Parkinson's disease.

Authors:  Yi Wang; Sheng Chen; Dehua Yang; Wei-dong Le
Journal:  J Neuroimmune Pharmacol       Date:  2007-05-09       Impact factor: 4.147

7.  Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.

Authors:  Ike Dela Peña; Se Jin Jeon; Eunyoung Lee; Jong Hoon Ryu; Chan Young Shin; Minsoo Noh; Jae Hoon Cheong
Journal:  Psychopharmacology (Berl)       Date:  2013-06-20       Impact factor: 4.530

8.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

9.  Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells.

Authors:  Ji-Yun Ko; Hyun-Seob Lee; Chang-Hwan Park; Hyun-Chul Koh; Yong-Sung Lee; Sang-Hun Lee
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

10.  Stem cells in development of therapeutics for Parkinson's disease: a perspective.

Authors:  Jiajie Xi; Su-Chun Zhang
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.